← Browse by Condition
Medical Condition

intracerebral hemorrhage

Total Trials
10
Recruiting Now
10
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for intracerebral hemorrhage sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — intracerebral hemorrhage Clinical Trials

How many clinical trials are currently recruiting for intracerebral hemorrhage?
ClinicalMetric currently tracks 10 actively recruiting clinical trials for intracerebral hemorrhage, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 10. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for intracerebral hemorrhage?
intracerebral hemorrhage research spans Phase 3 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a intracerebral hemorrhage clinical trial?
Eligibility criteria for intracerebral hemorrhage trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
2
Top Sponsors
Xuanwu Hospital, Beijing 1 trial
Beijing Tiantan Hospital 1 trial
Xiaolei Chen 1 trial
Zeenat Qureshi Stroke Institute 1 trial
Pirogov Russian National Research Medical University 1 trial

Recruiting Clinical Trials

NCT07166146
Recruiting
Timing and Outcomes of Recovery After intraCerebral Hemorrhage
Enrollment
500 pts
Location
China
Sponsor
Xuanwu Hospital, Beijing
View Trial →
NCT07338175 Phase 3
Recruiting
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
Enrollment
1,192 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT07077343
Recruiting
AI-Guided Hematoma Aspiration vs. Conservative Treatment for Spontaneous ICH
Enrollment
680 pts
Location
China
Sponsor
Xiaolei Chen
View Trial →
NCT06402968
Recruiting
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Enrollment
1,018 pts
Location
United States
Sponsor
Zeenat Qureshi Stroke Institut...
View Trial →
NCT06753786
Recruiting
Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage
Enrollment
200 pts
Location
Russia
Sponsor
Pirogov Russian National Resea...
View Trial →
NCT06462274
Recruiting
Biomarkers and Imaging Markers for ICH
Enrollment
200 pts
Location
China
Sponsor
Southwest Hospital, China
View Trial →
NCT06443268
Recruiting
Cerebrovascular Disease: Quality of Life (CODE: QoL)
Enrollment
680 pts
Location
Switzerland
Sponsor
University of Zurich
View Trial →
NCT05679024 Phase 3
Recruiting
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Enrollment
1,400 pts
Location
Finland, Iceland, No...
Sponsor
Region Stockholm
View Trial →
NCT06548737
Recruiting
Clinical Outcomes Following Primary Intracerebral Hemorrhage
Enrollment
25,000 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT05504941
Recruiting
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
Enrollment
15 pts
Location
Switzerland
Sponsor
University Hospital, Basel, Sw...
View Trial →

Related Conditions

stroke (3) intracerebral haemorrhage (1) hypertension (1) venous thromboembolism (1) pulmonary embolism (1) deep vein thrombosis (1) quality of life (1) stroke acute (1) sexual behavior (1) stress (1) cortisol excess (1) incontinence urinary (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology